Van ECK Associates Corp Has $211.57 Million Position in Nutrien Ltd. $NTR

Van ECK Associates Corp lifted its stake in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 44.8% during the 2nd quarter, HoldingsChannel reports. The firm owned 3,360,919 shares of the company’s stock after acquiring an additional 1,039,358 shares during the period. Van ECK Associates Corp’s holdings in Nutrien were worth $211,574,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. CORDA Investment Management LLC. acquired a new position in Nutrien during the second quarter worth $33,209,000. Vanguard Group Inc. boosted its stake in shares of Nutrien by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company’s stock valued at $1,386,546,000 after purchasing an additional 479,834 shares in the last quarter. Bryn Mawr Trust Advisors LLC bought a new stake in shares of Nutrien in the 2nd quarter worth about $8,363,000. Geode Capital Management LLC grew its holdings in shares of Nutrien by 6.8% in the 4th quarter. Geode Capital Management LLC now owns 4,833,284 shares of the company’s stock worth $304,217,000 after purchasing an additional 309,025 shares during the last quarter. Finally, Oxbow Advisors LLC increased its position in shares of Nutrien by 35.2% during the 4th quarter. Oxbow Advisors LLC now owns 142,981 shares of the company’s stock worth $8,825,000 after purchasing an additional 37,246 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Up 0.8%

Shares of NYSE NTR opened at $73.64 on Friday. The firm’s 50-day simple moving average is $67.33 and its 200 day simple moving average is $70.56. The company has a market cap of $35.23 billion, a price-to-earnings ratio of 14.91, a price-to-earnings-growth ratio of 0.78 and a beta of 0.61. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36. Nutrien Ltd. has a 12-month low of $53.03 and a 12-month high of $85.36.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The company had revenue of $10.81 billion for the quarter, compared to the consensus estimate of $10.44 billion. Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The firm’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned $2.65 EPS. On average, research analysts expect that Nutrien Ltd. will post 4.71 earnings per share for the current fiscal year.

Nutrien Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Tuesday, September 29th. Nutrien’s dividend payout ratio is 44.53%.

Key Stories Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
  • Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
  • Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
  • Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Wall Street Analysts Forecast Growth

NTR has been the subject of several analyst reports. Barclays cut their price target on shares of Nutrien from $81.00 to $78.00 and set an “overweight” rating for the company in a report on Monday, August 10th. BNP Paribas Exane raised shares of Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 price objective for the company in a report on Tuesday, July 28th. TD Securities reiterated a “buy” rating on shares of Nutrien in a research note on Wednesday, May 6th. Raymond James Financial raised Nutrien from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $74.00 to $90.00 in a report on Tuesday, May 5th. Finally, Wall Street Zen lowered Nutrien from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Seventeen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Nutrien presently has an average rating of “Moderate Buy” and an average price target of $81.58.

Get Our Latest Report on Nutrien

Nutrien Company Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

See Also

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.